Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Bitcoin and the Case of the Fork That Wasn’t

By Dana Blankenhorn, InvestorPlace Contributor
Bitcoin shows us how even without government there remains government. Government of the strong, by the ruthless, rather than for the people.

Toronto-Dominion Bank (TD) a Buy on Robust Earnings Visibility

By Portfolio Grader
Currently, Toronto-Dominion Bank (NYSE:TD) has a Buy using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking TD has had from Portfolio Grader for the last month.

Medtronic (MDT) Rating Dropped to Sell

By Portfolio Grader
Portfolio Grader currently ranks Medtronic Plc (NYSE:MDT) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. MDT has been downgraded from a Hold to a Sell in the last week.

Royal Bank of Canada’s (RY) Solid Earnings Visibility Make it a Buy

By Portfolio Grader
The current recommendation of Buy for Royal Bank of Canada (NYSE:RY) is the result of using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. RY has maintained this ranking for 5 months.

Weakening Industry Group Rank Drops Citigroup (C) to Hold

By Portfolio Grader
Citigroup Inc (NYSE:C) is one of the 765 companies in the GICS Financials sector, and a member of the 343 company Banks GICS industry group within this sector. The market value of C is $191.0 billion which falls in the top decile in its industry group. The ranking for C by Portfolio Grader places it 116 among the 343 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 277 among the 765 companies in the sector, and number 1,868 in the nearly 5,000 company Portfolio Grader universe.

For Apple Inc. Stock, It’s All About Growing Services

By Dana Blankenhorn, InvestorPlace Contributor
For Apple to keep rising, AAPL stock needs a boost from consumer adoption of augmented reality, which is fully supported by the iPhone X.

Robust Earnings Momentum Make HSBC Holdings plc Sponsored ADR (HSBC) a Buy

By Portfolio Grader
With a $198.5 billion market value, HSBC Holdings plc Sponsored ADR (NYSE:HSBC) ranks in the top decile in its industry group, Banks, and in the top 10% of its sector group, Financials, in market value. From the prospective of investment attractiveness, Portfolio Grader's current ranking for HSBC puts it 64 among the 343 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 161 among the 765 companies in the sector, and number 1,026 in the nearly 5,000 company Portfolio Grader universe.

Industry Group Rank Make Wells Fargo & Co (WFC) a Sell

By Portfolio Grader
Wells Fargo & Co (NYSE:WFC) ranks in the top 10% of its industry group, Banks, and in the top 10% of its sector group, Financials, with a market value of $265.2 billion. From an investment attractiveness prospective, WFC is ranked squarely in the bottom quartile of the sector with a ranking of 596 among the 765 companies in the sector; the current Portfolio Grader ranking for WFC puts it 264 among the 343 companies in this industry group, a position that is well below-average and number 3,653 in the 5000 company Portfolio Grader company universe.

Fading Sales Growth Drops Bank of America (BAC) to Hold

By Portfolio Grader
The current recommendation of Hold for Bank of America Corp (NYSE:BAC) is derived using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. BAC has been downgraded from a Buy to a Hold in the last week.

After a Lackluster 2017, Is It Time to Sell Walt Disney Co Stock?

By Lucas Hahn, InvestorPlace Contributor
Disney had an unexciting year, with all but one division shrinking, but is this cause for concern for Walt Disney stock?

JPMorgan Chase & Co (JPM) a Buy on Healthy Earnings Growth

By Portfolio Grader
JPMorgan Chase & Co (NYSE:JPM) is a $338.3 billion in market value constituent of the Banks GICS industry group where Portfolio Grader's current ranking for JPM puts it 91 among the 343 companies in this industry group, placing it in the top half. JPM is ranked in the top half of the sector with a ranking of 223 among the 765 companies in the sector and number 1,499 in the 5000 company Portfolio Grader company universe.

Berkshire Hathaway Energy (BRK.B) a Hold on Feeble Earnings Momentum

By Portfolio Grader
Berkshire Hathaway Energy Co (NYSE:BRK.B) is a constituent of the 17 company Diversified Financial Services GICS industry group, which is a segment of the 765 company GICS Financials sector. BRK.B's market value is $453.2 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 13 among the 17 companies in this industry group, a position that is well below-average; in the third quartile of the sector with a ranking of 394 among the 765 companies in the sector, and number 2,534 in the nearly 5,000 company Portfolio Grader universe.

Banco Santander Brasil (BSBR) Sees Downgrade….. Poor Industry Group Rank

By Portfolio Grader
As one of the 765 companies in the GICS Financials sector Banco Santander Brasil SA (NYSE:BSBR) is a component of the 343 company Banks GICS industry group within this sector. BSBR has a market value of $34,403.0 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for BSBR puts it 127 among the 343 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 297 among the 765 companies in the sector, and number 2,042 in the nearly 5,000 company Portfolio Grader universe.

Can a Semi Truck Drive Tesla Inc Stock If All Eyes Are on the Model 3 Car?

By Bret Kenwell, InvestorPlace Contributor
TSLA stock was on the move, climbing in anticipation of the new Tesla semi truck unveil this week. Can it continue its run?

Strong Sales Growth Make Vertex Pharmaceuticals (VRTX) a Buy

By Portfolio Grader
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is ranked as a Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Analytics for Industry Group Rank Keep MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
MLP & Strategic Equity Fund (NASDAQ:MTP) is a $40.9 billion in market value component of the Biotechnology GICS industry group where the current Portfolio Grader ranking for MTP puts it 273 among the 349 companies in this industry group, a position that is well below-average. MTP is ranked squarely in the bottom quartile of the sector with a ranking of 624 among the 782 companies in the sector and number 3,832 in the 5000 company Portfolio Grader company universe.

Analytics for Industry Group Rank Make Shire (SHPG) a Sell

By Portfolio Grader
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SHPG has had from Portfolio Grader for 11 months.

Weak Quant Score Restrict Regeneron Pharmaceuticals (REGN) Rating

By Portfolio Grader
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is one of 349 companies within the Biotechnology GICS industry group, which is in turn part of the 782 company GICS Health Care sector. REGN has a market value of $43.4 billion which is in the top 10% of its industry group. The ranking for REGN by Portfolio Grader places it 173 among the 349 companies in this industry group, giving it an above-average position; in the third quartile of the sector with a ranking of 404 among the 782 companies in the sector, and number 2,615 in the nearly 5,000 company Portfolio Grader universe.

Solid Quant Score Make Cellect Biotechnology (APOP) a Buy

By Portfolio Grader
With a $44.3 billion market value, Cellect Biotechnology Ltd (NULL:APOP) ranks in the top 10% of its industry group, Biotechnology, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's Portfolio Grader ranking places it 37 among the 349 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 107 among the 782 companies in the sector, and number 707 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles